drugset / Trial / NCT06435065

Direct Pulp Capping Agent on Human Pulp Tissue

NCT06435065

Phase 4 Unknown 40 enrolled DR SURINDER SACHDEVA
RandomizedParallel-groupSingle-blindTreatment

Summary

This in- vivo study was conducted to evaluate the response of human pulp tissue following direct pulp capping using four different pulp capping agents in premolars scheduled for extraction in patients undergoing orthodontic treatment.

Timeline

Start
2024-04-01
Primary completion
2024-06
Completion
2024-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Biodentine Other / unclassified
Comparator Mineral Trioxide Aggregate Other / unclassified
Comparator TRISTRONTIUM ALUMINATE Unknown
Comparator Theracal LC Other / unclassified

Indications